透析市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Dialysis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月07日 | 出版商:

Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球透析市场估值为921 亿美元，预计2024 年至2032 年复合年增长率为5.5%。以及人口老化以及家庭透析解决方案的日益普及。透析设备的创新发展，例如便携式机器、家庭透析系统和更有效率的透析解决方案，改善了患者的治疗效果并提供了更大的便利性。这些创新减少了治疗时间并提高了灵活性，特别是在居家透析和穿戴式科技日益增长的趋势下。这种转变不仅提高了患者的生活质量，也有助于减轻医疗机构的压力。

根据治疗类型，市场分为血液透析和腹膜透析。 2023年，血液透析领域的收入为795亿美元，使其成为领先的治疗方式。血液透析对于治疗晚期 CKD 和末期肾病 (ESRD) 至关重要，因为它可以过滤血液中的废物和多余液体。心血管疾病是肾臟损害的主要原因，它继续导致血液透析需求不断增长，随着心臟病仍然普遍存在，预计需求将会增加。

就产品和服务而言，市场分为服务、消耗品和设备。 2023 年，服务领域占据主导地位，占 79% 的市场。透析中心的扩张，特别是在城市和城乡结合部地区，增加了获得重要治疗的机会。主要透析提供者正在 CKD 高发生率地区投资建设更多设施，以支持住院和门诊服务的成长。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	921 亿美元
预测值	1,481 亿美元
复合年增长率	5.5%

这种扩张是确保更多患者获得一致照护的关键。北美在 2023 年以 318 亿美元的收入引领市场，预计到 2032 年将以 5.4% 的复合年增长率成长。新的创新，例如更有效率的血液透析机、便携式腹膜透析系统和家用透析设备，提高了患者的舒适度并改善了临床结果。这些发展正在增加先进透析解决方案的采用，从而改善整个北美地区获得肾臟护理服务的机会。

产业生态系统分析
产业影响力
- 成长动力
  - 末期肾病 (ESRD) 患者数量不断增加
  - 糖尿病发生率增加
  - 供肾短缺
  - 透析治疗可获得有利的报销方案
  - 已开发国家和开发中国家的研发投资不断增加
- 产业陷阱与挑战
  - 产品召回
  - 治疗中的併发症
成长潜力分析
监管环境
报销场景
技术景观
价值链分析
波特的分析
PESTEL分析
差距分析
未来市场趋势

第 4 章：竞争格局

介绍
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

主要趋势
血液透析
腹膜透析

第 6 章：市场估计与预测：按产品和服务划分，2021 - 2032 年

主要趋势
服务
- 慢性透析
- 急性透析
耗材
- 透析器
- 导管
- 接入产品
- 浓缩物
- 其他消耗品
装置
- 透析机
- 水处理系统
- 其他设备

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
中心透析
居家透析

第 8 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 波兰
- 瑞典
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 印尼
- 菲律宾
- 马来西亚
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 智利
- 哥伦比亚
- 秘鲁
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 以色列
- 土耳其
- 埃及
- MEA 的其余部分

第 9 章：公司简介

AngioDynamics, Inc.
Asahi Kasei Corporation
B. Braun Holding GmbH & Co. KG
Baxter International Inc.
Becton, Dickinson and Company
DaVita Inc.
Dialife SA
Fresenius SE and Co. KGaA
JMS Co Ltd
KAWASUMI LABORATORIES INC
Medtronic Plc.
Nikkiso Co. Ltd.
Nipro Medical Corporation
Rogosin Institute
Satellite Healthcare
Teleflex Incorporated
Toray Industries Inc.
US Renal Care, Inc.

简介目录

Product Code: 3001

The Global Dialysis Market was valued at USD 92.1 billion in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2032. This growth is driven by advancements in dialysis technologies, an increasing prevalence of chronic kidney disease (CKD), an aging population, and the rising adoption of home-based dialysis solutions. Innovative developments in dialysis equipment, such as portable machines, home dialysis systems, and more efficient dialysis solutions, improve patient outcomes and offer greater convenience. These innovations reduce treatment times and enhance flexibility, particularly with the growing trend toward home dialysis and wearable technologies. This shift not only improves patient quality of life but also helps reduce the strain on healthcare facilities.

The market is segmented into hemodialysis and peritoneal dialysis based on treatment type. In 2023, the hemodialysis segment accounted for USD 79.5 billion in revenue, making it the leading treatment modality. Hemodialysis is essential for managing advanced CKD and end-stage renal disease (ESRD), as it filters waste and excess fluids from the blood. Cardiovascular diseases, a leading cause of kidney damage, continue to contribute to the growing need for hemodialysis, with demand expected to rise as heart disease remains prevalent.

In terms of products and services, the market is categorized into services, consumables, and equipment. The services segment dominated in 2023, capturing 79% of the market share. The expansion of dialysis centers, especially in urban and semi-urban areas, has increased access to vital treatment. Major dialysis providers are investing in more facilities in regions with a high prevalence of CKD, supporting the growth of both in-hospital and outpatient services.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$92.1 Billion
Forecast Value	$148.1 Billion
CAGR	5.5%

This expansion is key to ensuring more patients receive consistent care. North America led the market with USD 31.8 billion in revenue in 2023 and is expected to grow at a 5.4% CAGR through 2032. The region benefits from continuous advancements in dialysis technologies and treatment options. New innovations, such as more efficient hemodialysis machines, portable peritoneal dialysis systems, and home dialysis devices, enhance patient comfort and improve clinical outcomes. These developments are increasing the adoption of advanced dialysis solutions, thus improving access to renal care services across North America.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
  - 3.2.1.2 Increasing incidence of diabetes
  - 3.2.1.3 Shortage of donor kidneys
  - 3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
  - 3.2.1.5 Growing R&D investments in developed as well as developing countries
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Product recalls
  - 3.2.2.2 Complications in the treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technology landscape
3.7 Value chain analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Gap analysis
3.11 Future market trends

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Hemodialysis
5.3 Peritoneal dialysis

Chapter 6 Market Estimates and Forecast, By Product and Services, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Services
- 6.2.1 Chronic dialysis
- 6.2.2 Acute dialysis
6.3 Consumables
- 6.3.1 Dialyzers
- 6.3.2 Catheters
- 6.3.3 Access products
- 6.3.4 Concentrates
- 6.3.5 Other consumables
6.4 Equipment
- 6.4.1 Dialysis machines
- 6.4.2 Water treatment systems
- 6.4.3 Other equipment

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 In-center dialysis
7.3 Home dialysis

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Poland
- 8.3.7 Sweden
- 8.3.8 Netherlands
- 8.3.9 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Indonesia
- 8.4.7 Philippines
- 8.4.8 Malaysia
- 8.4.9 Rest of APAC
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Chile
- 8.5.5 Colombia
- 8.5.6 Peru
- 8.5.7 Rest of LATAM
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Israel
- 8.6.5 Turkey
- 8.6.6 Egypt
- 8.6.7 Rest of MEA